Session Information
-
WCLC 2019
2019 World Conference on Lung Cancer
Conference Program for the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2970
September 7 Sat
Sep 7 Sunday
September 8 Sun
Sep 8 Monday
September 9 Mon
Sep 9 Tuesday
September 10 Tue
Sep 10
-
+
P1.12 - Small Cell Lung Cancer/NET
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Small Cell Lung Cancer/NET
-
+
P1.12-22 - A Phase 1b/2 Study of Niraparib Plus Temozolomide Versus Standard Care as Maintenance Therapy in Extensive-Stage Small Cell Lung Cancer Patients
09:45 - 09:45 | Presenter: Amy Lauren Cummings | Author(s): Edward Garon, Zev A Wainberg, Jonathan Goldman
- Abstract
Loading...
-
+
PL02 - Presidential Symposium including Top 7 Rated Abstracts
- 08:00 - 10:15
- 9/09/2019
- Location: Barcelona (2005)
- IASLC CME Accredited
- Type: Plenary Session
- Track:
- Moderators:Giorgio Vittorio Scagliotti, Ramon Rami-Porta
-
+
PL02.11 - Overall Survival with Durvalumab Plus Etoposide-Platinum in First-Line Extensive-Stage SCLC: Results from the CASPIAN Study
09:38 - 09:48 | Presenter: Luis Paz-Ares | Author(s): Yuanbin Chen, Niels Reinmuth, Katsuyuki Hotta, Dmytro Trukhin, Galina Statsenko, Maximilian J. Hochmair, Mustafa Özgüroğlu, Jun Ho Ji, Oleksandr Voitko, Artem Poltoratskiy, Santiago Ponce, Francesco Verderame, Libor Havel, Igor Bondarenko, Andrzej Kazarnowicz, György Losonczy, Nikolay V. Conev, Jon Armstrong, Natalie Byrne, Norah Shire, Haiyi Jiang, Jonathan Goldman
- Abstract
Loading...
-
+
MA11 - Immunotherapy in Special Populations and Predictive Markers
- 14:00 - 15:30
- 9/09/2019
- Location: Hilton Head (1978)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Immuno-oncology
- Moderators:Frank Griesinger, Lecia Sequist
-
+
MA11.11 - STK11/LKB1 Genomic Alterations Are Associated with Inferior Clinical Outcomes with Chemo-Immunotherapy in Non-Squamous NSCLC
15:10 - 15:15 | Presenter: John Victor Heymach | Author(s): Ferdinandos Skoulidis, Kathryn C. Arbour, Matthew Hellmann, Pradnya Dinkar Patil, Melina E Marmarelis, Dwight Hall Owen, Mark Awad, Joseph C. Murray, Benjamin Philip Levy, Jessica Hellyer, Justin F. Gainor, Tyler Stewart, Sarah B. Goldberg, Anastasios Dimou, Christine M Bestvina, Amy Lauren Cummings, Yasir Elamin, Vincent Lam, Jianjun Zhang, Catherine Shu, Jonathan Wesley Riess, Collin M Blakely, Chad V. Pecot, Laura Mezquita, Fabrizio Tabbò, Adrian G Sacher, Matthias Scheffler, Biagio Ricciuti, Deepti Venkatraman, Hira Rizvi, Corinne Liu, Rocio Perez Johnston, Ying Ni, Joseph Azok, Melanie Wain Kier, Sharyn I Katz, Kurtis D. Davies, Jeremy P Segal, Lauren Ritterhouse, Hiram Shaish, LUDOVIC Lacroix, Regan Memmott, John R Madrigal, Jonathan Goldman, Sally CM Lau, Jonathan Killam, Zenta Walther, Brett Carter, Mark Woodcock, Jack Roth, Stephen Swisher, Natasha B Leighl, Subba Digumarthy, Meghan Mooradian, Julia Rotow, Juergen Wolf, Giorgio Vittorio Scagliotti, David Planchard, Benjamin Besse, Trever G Bivona, David R Gandara, Edward Garon, Naiyer A Rizvi, D. Ross Camidge, Kurt A Schalper, Roy S. Herbst, Alice T. Shaw, Joel W Neal, Heather A Wakelee, Julie R Brahmer, Pasi A Jänne, David P Carbone, Charu Aggarwal, Nathan Pennell, Charles M Rudin, Vassiliki A Papadimitrakopoulou
- Abstract
Loading...
-
+
MA14 - The Adequate MTarget Is Still the Issue
- 15:45 - 17:15
- 9/09/2019
- Location: Hilton Head (1978)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Advanced NSCLC
- Moderators:Diego Signorelli, Juergen Wolf
-
+
MA14.03 - EGFR M+ Subgroup of Phase 1b Study of Telisotuzumab Vedotin (Teliso-V) Plus Erlotinib in c-Met+ Non-Small Cell Lung Cancer
15:55 - 16:00 | Presenter: D. Ross Camidge | Author(s): Fabrice Barlesi, Jonathan Goldman, Daniel Morgensztern, Rebecca S Heist, Everett E. Vokes, Alex Spira, Eric Angevin, Wu-Chou Su, David S. Hong, John H. Strickler, Monica Motwani, Zhaowen Sun, Apurvasena Parikh, Philip Komarnitsky, Jun Wu, Karen Kelly
- Abstract
Loading...
-
+
P2.12 - Small Cell Lung Cancer/NET
- 10:15 - 18:15
- 9/09/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Small Cell Lung Cancer/NET
-
+
P2.12-09 - Phase 2 Study of Talazoparib Plus Low-Dose Temozolomide in Patients with Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer
10:15 - 10:15 | Presenter: Jonathan Goldman | Author(s): Amy Lauren Cummings, Melody Mendenhall, David E. Kanamori, Anthony Nguyen, David Dae-Young Kim, Zev A Wainberg
- Abstract
Loading...
